1-N,3-N-bis(2-aminoethyl)-5-[5-[5-[3-[(2-aminoethylamino)methyl]-5-(2-aminoethylcarbamoyl)phenyl]-2-methylphenyl]heptan-3-yl]benzene-1,3-dicarboxamide

• 分子结构分类: 有机化合物 - 木脂素、新木脂素和相关化合物
• 英文名称: 1-N,3-N-bis(2-aminoethyl)-5-[5-[5-[3-[(2-aminoethylamino)methyl]-5-(2-aminoethylcarbamoyl)phenyl]-2-methylphenyl]heptan-3-yl]benzene-1,3-dicarboxamide
• 化学式: C₃₈H₅₆N₈O₃
• 分子量: 672.9
• InChiKey: JNBPYUJYMCRLSQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  49
• 可旋转键数：
  20
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  203
• 氢给体数：
  8
• 氢受体数：
  8

文献信息

• [EN] POLYCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME<br/>[FR] COMPOSÉS POLYCYCLIQUES ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION
  申请人：CELLCEUTIX CORP

  公开号：WO2014093225A2

  公开（公告）日：2014-06-19

  The present disclosure provides compounds, or pharmaceutically acceptable salts thereof, for inhibiting the growth of a microbe; treating a mammal having a microbial infection, malaria, mucositis, an ophthalmic infection, an otic infection, a cancer, or a Mycobacterium infection; killing or inhibiting the growth of a Plasmodium species; inhibiting the growth of a Mycobacterium species; modulating an immune response in a mammal; or antagonizing unfractionated heparin, low molecular weight heparin, or a heparin/low molecular weight heparin derivative.